Hypha Labs (OTCMKTS:DIGP) & SunocoCorp (NYSE:SUNC) Head-To-Head Contrast

Hypha Labs (OTCMKTS:DIGP) and SunocoCorp (NYSE:SUNC) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, profitability, institutional ownership, valuation and earnings.

Profitability

This table compares Hypha Labs and SunocoCorp’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Hypha Labs	N/A	N/A	-35.56%
SunocoCorp	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of current ratings and target prices for Hypha Labs and SunocoCorp, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hypha Labs	0	0	0	0	0.00
SunocoCorp	1	0	2	1	2.75

SunocoCorp has a consensus target price of $64.00, indicating a potential upside of 6.26%. Given SunocoCorp’s stronger consensus rating and higher possible upside, analysts clearly believe SunocoCorp is more favorable than Hypha Labs.

Valuation and Earnings

This table compares Hypha Labs and SunocoCorp”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hypha Labs	$2.70 million	1.11	$250,000.00	N/A	N/A
SunocoCorp	N/A	N/A	N/A	N/A	N/A

Hypha Labs has higher revenue and earnings than SunocoCorp.

Summary

SunocoCorp beats Hypha Labs on 5 of the 6 factors compared between the two stocks.

About Hypha Labs

Hypha Labs, Inc., cultivates, produces, and sells psychedelic and functional mushroom in the United States. It has developed technology that quickly cultivates the mycelium root structures of psilocybin mushrooms and other functional mushroom's mycelium into a natural product. The company was incorporated in 2010 and is headquartered in Las Vegas, Nevada.

About SunocoCorp

Sunoco LP is an energy infrastructure and fuel distribution master limited partnership. Sunoco LP is based in DALLAS.